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We describe conditions under which exogenous DNA templates can be introduced for transient expression
into primary murine T lymphocytes. T cells at various stages of development, including concanavalin
A-activated splenic T cells, immature pre-T cells, and even small cortical thymocytes, could be successfully
transfected. A variety of model DNA constructs were compared in which different viral promoter regions were
used to drive expression of the chloramphenicol acetyltransferase (CAT) reporter gene. All showed enhanced
expression in cells that had been acutely stimulated with the Ca2+ ionophore A23187 and phorbol ester as
chemical proxies for T-cell receptor-mediated signals. In addition, splenocytes but not thymocytes required
prior treatment with a mitogen and interleukin-2 in order to express these constructs, implying that even
postmitotic thymocytes may be held in a quasiactivated state. A most striking result was the finding that the
viral regulatory sequences in the Rous sarcoma virus long terminal repeat and the simian virus 40 early region
were subject to sharply differential regulation, with a rank order that changed depending on the developmental
stage of the T cells. The most immature thymic blasts and several lymphoma cell lines expressed the pRSV-Cat
and pSV2-Cat constructs similarly, but cortical thymocytes exhibited a strong preference for pSV2-Cat.
Splenic concanavalin A-stimulated blasts, on the other hand, slightly preferred pRSV-Cat, a tendency which
became exaggerated in factor-dependent T-cell lines. The ratio of pRSV-Cat to pSV2-Cat expression varied
according to cell type by as much as 500-fold. These results argue against a trivial linkage of promoter preference
to cell cycle status but instead provide evidence that activation ofT cells at distinct stages of differentiation results
in the expression ofdifferent ensembles ofnuclear regulatory proteins. In contrast to the simian virus 40 and Rous
sarcoma virus promoter regions, the long terminal repeats of the retroviruses mink cell focus-forming virus and
Akv were expressed well in all primary T-lineage cells. Thus, they represent excellent model promoters for
engineering developmental stage-independent expression of exogenous genes in murine T cells.
Mature T lymphocytes comprise functionally distinct sub-
sets with discrete roles in the regulation of the immune
response. Although this specialization results from differ-
ences in gene expression, the signals which drive this
differentiative process are only beginning to be understood.
Transfection experiments with T-cell-specific genes have
identified both trans-acting factors and cis regulatory regions
which contribute to lineage-specific expression (reviewed in
reference 59). In general, these experiments utilize immor-
talized cell lines which are more easily transfected than are
primary T cells. However, although established cell lines are
of tremendous value in the study of T-cell biology, it is likely
that they differ in important ways from their normal coun-
terparts. It is especially difficult to find appropriate models
for cortical thymocytes, which are developmental interme-
diates at a critical three-way choice point in T-cell differen-
tiation, poised between death on the one hand and matura-
tion along one of at least two different lineages. Whereas
most of these cells, in situ, are destined to die, the majority
of cell lines established from them are rapidly dividing
thymomas.
Alterations in the repertoire of transcription factors should
both reflect and mediate the functional changes in develop-
ing T cells. Accordingly, there are striking differences in the
abilities of various thymocyte subsets to express immune
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response-associated genes (5, 6, 47, 50, 51), which in some
cases have been shown to correlate with the presence or
absence of known transcription factors (lla, 45). Although
the presence or absence of many transcription factors can be
determined by DNA footprinting and electrophoretic mobil-
ity shift assays, such an experimental approach requires
prior knowledge of the DNA region to be tested. Even when
discrete protein-binding sites are demonstrated in a gene
regulatory region, direct transfection experiments are often
required to confirm that such sites are functionally important
in vivo. In such cases, it would be advantageous to assay
regulatory DNA sequences directly in the cells of interest
rather than in model cell lines. This is absolutely necessary
when it is the differences among constituents of the cell's
transcriptional machinery in different developmental states
that are being assessed. Therefore, we set out in this work to
develop conditions for measuring transcriptional utilization
of exogenous DNA templates in freshly isolated thymocytes
and peripheral T cells.
As a first step, the transfectability of a variety of primary
T-cell populations was assessed by measuring their ability to
utilize two broadly expressed positive control promoters,
the simian virus 40 (SV40) early promoter and the Rous
sarcoma virus (RSV) long-terminal repeat (LTR), as well as
the LTRs of two retroviruses implicated in thymic leukemia,
mink cell focus-forming virus type 13 (MCF-13) and Akv.
Our results demonstrate that thymocytes from both normal
and SCID mutant mice express easily detectable levels of
chloramphenicol acetyltransferase (CAT) activity following
transfection under appropriate conditions. The MCF and
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Akv promoters are expressed well by all primary popula-
tions. On the other hand, the relative strength of the RSV
and SV40 viral promoters is dependent on the type of T cell
transfected. A strong preference for RSV over SV40 is seen
in established T-cell lines which retain their interleukin-2
(IL-2) dependence, but both are expressed equally in cell
lines which are factor independent for growth. By contrast,
freshly isolated cortical thymocytes show a marked bias in
favor of the SV40 early region over the RSV LTR. In
general, after T cells migrate from the thymus, they lose
their strong preference for the SV40 early promoter, a shift
which probably reflects a developmental shift in the battery
of trans-acting factors that they possess.
MATERUILS AND METHODS
Reagents. The phorbol ester 12-O-tetradecanoylphorbol
13-acetate (TPA) and the calcium ionophore A23187 were
used at final concentrations of 10 and 37 ng/ml, respectively.
Concentrated stock solutions made up in dimethyl sulfoxide
(DMSO) and stored at -20°C were diluted in growth medium
immediately prior to use.
Cell lines. The IL-2-independent cell lines EL4.E1, Jurkat,
BW5147, R1.1, AO1T-2.11 (53), 629, 705, and 728 (44) were
grown in RPMI 1640 supplemented with 10% fetal bovine
serum (FBS), 2 mM L-glutamine, 5 x 10'5 M 2-mercapto-
ethanol, 10 mM N-2-hydroxyethylpiperazine-N'-2-ethane-
sulfonic acid (HEPES; pH 7), and antibiotics (full medium).
The IL-2-dependent lines MTL2.8.2, CTLL-2, and HT-2
were maintained in full medium containing 5% conditioned
medium (CM) from TPA-stimulated EL4.E1 cells as a source
of IL-2. The IL-3-dependent premast cell line 32Dcl5 was
grown in Dulbecco modified Eagle medium (DMEM) con-
taining 10% FBS supplemented with 20% WEH1-3B CM as
a source of IL-3.
All cell lines are of murine origin except Jurkat, which is a
human cell line.
Plasmid DNA and transfections. Plasmids pSV2-Cat and
pRSV-Cat were provided by B. Howard and C. Gorman
(National Institutes of Health) and have been described
previously (24, 25). pUC18-Cat contains a SphI-BamHI
fragment from pSV2-Cat inserted into the SphI-HindIII sites
of pUC18. This construct contains only 22 bp of the SV40
enhancer region and therefore lacks effective enhancing
activity (25). In plasmids pMCF-Cat and pAkv-Cat, the
SV40 promoter has been removed from pUC18-Cat by
digestion with PstI and HindIII and replaced with PstI-SmaI
LTR fragments from the retroviruses MCF-13 and Akv
mouse leukemia virus, respectively. Plasmids pMS1 and
pAS1 contain 326-bp PstI-DraI enhancer fragments from
MCF-13 and Akv, respectively, inserted into theXbaI site in
the polylinker region of pUC18-Cat. They therefore include
the MCF or Akv enhancer, with the SV40 promoter proper.
The LTR fragments used in these constructs have been
described in detail previously (29).
All plasmid DNAs were purified on cesium chloride-
ethidium bromide density gradients before use.
Cell lines were transfected by DEAE-dextran facilitation
essentially as described previously (42). Briefly, cells were
washed once in full medium and then once in serum-free
DMEM containing 10 mM HEPES, pH 7.0 (DMEM/H).
After the second wash, cells were resuspended at 107/ml in
DMEM/H containing 250 ,ug of DEAE-dextran (molecular
weight, 2 x 106) per ml, 0.1 mM chloroquine, and 10 ,ug of
supercoiled plasmid DNA per ml. Cells were put in a
37°C-7% CO2 incubator for 60 min (30 min for EIA.E1 cells)
with occasional swirling. The cells were then diluted with -3
volumes of DMEM/H and pelleted. EL4.E1 cells were
washed a further time in DMEM/H plus 150 U of heparin per
ml to reduce cell clumping. Modifications of this protocol to
allow efficient transfection of primary T cells and thymo-
cytes are described below.
Twenty-four hours posttransfection, cells received either
DMSO (solvent control) or TPA-A23187. Cells were har-
vested 18 h later, counted to determine viability, and lysed
as previously described (42).
Calculation of relative promoter strength. Lysates from
equal viable cell numbers were assayed for CAT activity in
a 5-h assay as previously described (42). After autoradiog-
raphy of the CAT assay thin-layer chromatography plate,
spots corresponding to [14C]chloramphenicol and its acety-
lated derivatives were cut out and counted. Background
counts per minute from mock-transfected cells were sub-
tracted from all experimental acetylated values, after which
the percent acetylation was calculated. All samples with less
than 0.01% acetylation were considered to be below the level
of detection. CAT activity was then normalized to a constant
number of viable cell equivalents, either 106 cells for lines or
107 cells for thymocytes and primary T cells. A major source
of variability between experiments was the irreproducible
survival of the cells through transfection and stimulation.
CAT activity per viable cell tended to be higher in experi-
ments in which the recovery of viable cells was lower. This
effect was difficult to control but appeared to reflect subtle
differences in the condition of the cells used in different
experiments, not sample-to-sample variation within an ex-
periment. The relative expression of different plasmids
within an experiment was much more consistent. Thus, the
relative promoter strength is presented as a ratio, R/S, which
is the ratio of normalized CAT activity in cells transfected
with pRSV-Cat to the activity in cells transfected with
pSV2-Cat. All comparisons of promoter strength were made
with cells that had been transfected on the same day with the
different plasmids. At least two separate preparations of
each plasmid were used with similar results.
Overall, the results reported were consistent over a period
of 3 years and repeated in two different labor-atories.
Thymocyte preparation. Thymuses were removed from
young C57BL/6 (B6), BALB/c, and C.B-17 scidiscid (SCID)
mice at 4 to 5 weeks of age, and single-cell preparations were
made by pressing the thymuses through a fine wire mesh
screen. Thymocytes were washed in full medium and were
either transfected immediately or separated into subsets
first. Because of the large numbers of cells required to detect
expression of transfected DNA, low-yield methods like
fluorescence-activated cell sorting could not be used. Size
fractionation of thymocytes by centrifugal elutriation and
complement elimination of CD8+ cells were performed ex-
actly as described previously (5). In most experiments, we
found it convenient to separate large numbers of thymocytes
into cortical and medullary populations by panning on pea-
nut agglutinin (PNA)-coated petri dishes. PNA panning was
done as described previously (10), with minor modifications.
Petri dishes (150-mm diameter) were coated with PNA the
previous day by incubation for 60 min at 25°C with 10 ml of
a solution containing 20 ,ug of PNA per ml in 50 mM Tris-150
mM NaCl, pH 9.5. Plates were washed extensively with
phosphate-buffered saline (PBS) containing Ca2" and Mg2+
(PBS+), overlaid with 10 ml of PBS+-1% FBS, and stored at
40C until use. For PNA fractionation, thymocytes were
resuspended in PBS+-5% FBS to a concentration of 2 x
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107/ml, and 10 ml was applied to each PNA-coated plate. The
plates were incubated at 4°C for 60 min with occasional
swirling. PNA- cells were decanted, and the plates were
washed twice with 10 ml of PBS+-1% FBS. These two
washes were combined with the PNA- cells. To remove
PNA+ cells, the plates were incubated at 37°C for 10 min
with 10 ml of PBS+-0.2 M methyl-a-D-galactopyranoside.
PNA+ cells were then dislodged with a plastic cell scraper
(Costar). The absence of azide in the PBS during panning
results in strong binding of the PNA+ cells to the plate,
allowing vigorous washing of the plates. Thus, there is very
little contamination of PNA- cells in the PNA+ fraction.
Fractionated thymocytes were washed several times with
full medium and transfected as described above for cell lines,
with the following modifications: (i) cells were transfected at
a density of 108/ml (107/ml for SCID thymocytes), (ii) trans-
fected thymocytes received TPA+A23187 2 to 5 h posttrans-
fection, and (iii) stimulation with TPA+A23187 was for only
12 h before cells were harvested and assayed for CAT
activity. The reduced time of incubation allowed even deli-
cate thymocytes to be recovered with good viability. Murine
cortical thymocytes could not be prestimulated with conca-
navalin A (ConA), as this treatment leads to rapid cell death
(49a). The uptake and expression of plasmid DNA in thymo-
cytes were similar whether or not the cells were cultured in
the presence of 5 mM Zn2+ to inhibit endogenous nucleases
(14a).
Spleen cell preparation. Spleens from 7- to 16-week-old
mice were teased in full medium and pressed through a wire
screen to produce a single-cell suspension. Erythrocytes
were lysed in Tris-buffered ammonium chloride, and viable
cells were further purified on a Ficoll-metrizoate cushion.
B-cell-depleted spleen cells were prepared by two rounds of
panning on goat anti-mouse immunoglobulin-coated plates.
Spleen cells were transfected at a density of 108/ml for 25
min, after which they were washed and put into culture.
Compared with these conditions, a cell density of 107/ml or
incubation times greater than 30 min resulted in a 75%
reduction of viable cells.
Twenty-four hours posttransfection, cells were stimulated
with TPA+A23187. They were harvested 18 h later for CAT
assay.
For experiments with ConA blasts, cells were cultured at
1 x 106 to 2 x 106/ml for 2 to 4 days in the presence of 4 p,g
of ConA (Vector) per ml. The cells were washed with PBS
plus 25 ,ug of methyl-a-D-mannopyranoside per ml before
transfection. Transfected cells were cultured in full medium
plus 5% ELA CM for 24 h before they were stimulated with
phorbol ester and ionophore.
DNA extraction and quantitation. PNA+ thymocytes and
CTLL-2 cells transfected in parallel with pRSV-Cat or
pSV2-Cat were analyzed 16 and 42 h later, respectively. One
half of the cells were assayed for CAT activity. The other
half were lysed by the method of Hirt (28a), and low-
molecular-weight DNA was isolated. DNA from 3 x 105 cell
equivalents was run in a 0.75% agarose gel and blotted onto
a nylon filter (Nytran; Schleicher & Schuell). Plasmid se-
quences were detected by hybridization to a pSP65 deriva-
tive plasmid probe (pTN42) labeled with [a-32P]dCTP by
random priming. Hybridization and wash conditions were as
described previously (41). After suitable autoradiographic
exposures were obtained, the regions of the filter containing
hybridized probe were excised and counted.
RESULTS
Cortical thymocytes can express exogenous DNA. The piv-
otal cell populations for analysis of the changes in gene
regulation during T-cell development are thymocytes. These
cells undergo dramatic changes in mitotic activity, respon-
siveness, and functional competence in the course of their
differentiation and selection before leaving the thymus (re-
viewed in references 1, 19, 20, 49, 51, and 60). To establish
model conditions for the study of immune response-associ-
ated gene regulation in thymocytes, we addressed the prob-
lems of viability, activation state, and functional heteroge-
neity in thymocytes.
First, cortical thymocytes, the cells at the point of choice
between positive, negative, and failed selection, are partic-
ularly refractory to in vitro stimulation and particularly easy
to kill by in vitro culture. To maintain their contribution to
the results, we modified our standard transfection procedure
to minimize the incubation time before assaying reporter
gene expression. Control transfection experiments using the
conditions described in Materials and Methods showed that
when thymocytes were incubated with plasmid DNA in the
presence of DEAE-dextran, they took up DNA in a time-
dependent fashion and maintained an average of -50 copies
of plasmid DNA per cell for at least 24 h (data not shown).
Second, since many function-associated genes are expressed
in T cells only after activation, we compared CAT activity in
transfected cells with and without a further activation step.
Chemical proxies for T-cell receptor (TcR)-generated sig-
nals, namely, the calcium ionophore A23187 plus the phor-
bol ester TPA, were used to allow stimulation of immature
and mature thymocytes alike (37, 51). Finally, because
responses of total thymocyte populations are usually domi-
nated by the minority of relatively mature thymocytes, we
compared the transfectability of total thymocytes with that
of thymocyte subsets fractionated by adherence to PNA.
PNA- cells are at least fivefold enriched for mature thymo-
cytes, while PNA+ cells are depleted of them. Usually over
90% of PNA+ cells have the cortical CD4+ CD8+ (double-
positive) surface phenotype, and all cells in this population
are characteristically unable to respond to induction by
expressing either IL-2 or the IL-2 receptor a chain (6, 37).
By contrast, the PNA- population is about fivefold enriched
for cells that are competent in these inducible functions (6,
37, 51). This enrichment of functionally mature cells corre-
lates well with corresponding four- to sixfold increases in the
percentages of cells with CD4+ CD8- or CD4- CD8+
single-positive phenotypes. Figure 1A shows an example of
the typical CD4/CD8 staining profiles of the PNA-fraction-
ated populations used for transfection. The results of trans-
fecting these thymocytes, and a summary of four such
experiments, are presented in Fig. 1B and 2 and in Table 1.
Thymocytes were clearly able to express CAT from exog-
enous DNA templates, particularly after a 12-h stimulation
with TPA+-A23187. The cells responsible for this expres-
sion appeared, surprisingly, to be cortical thymocytes.
PNA+ thymocytes expressed 2 to 20 times more CAT
activity per cell than did total thymocytes or PNA- cells,
depending on the construct used (Fig. 1B; compare SV2
lanes; Tables 1 and 2). This is unlikely to reflect the presence
of small numbers of contaminating CD4+ CD8- cells in the
PNA+ fraction, since the ability to express CAT was nega-
tively correlated with the presence of such mature-type
cells. CD4+ CD8- cells in general are at least fivefold more
concentrated in the PNA- fraction, which is less able to
express CAT. Indeed, as our fractionation procedure leaves
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FIG. 1. Assay of CAT activity in thymocytes transfected with pRSV-Cat and pSV2-Cat. (A) CD4/CD8 staining profiles of starting
populations. Total thymocytes, PNA- cells, and PNA+ cells from 4-week-old B6 mice were stained simultaneously with phycoerythrin-
conjugated anti-CD4 and fluorescein isothiocyanate-conjugated anti-CD8 monoclonal antibodies (Becton Dickinson) and analyzed on a
FACScan (Becton Dickinson). The distribution of cells is representative of four experiments. The fraction of cells in each population is as
follows: total, 13% CD4+, 81% CD4+CD8+, 2% CD4-CD8-, 4% CD8+; PNA-, 37% CD4+, 47% CD4+CD8+, 4% CD4-CD8-, 12% CD8+;
PNA+, 8% CD4+, 90% CD4+CD8+, 0.4% CD4-CD8-, 2% CD8+. (B) CAT assay of transfected thymocytes after 12 h of stimulation with
phorbol ester and ionophore. Total PNA- and PNA+ thymocytes whose staining profiles are shown in panel A were transfected with pBR322
(pBR), pRSV-Cat (RSV), or pSV2-Cat (SV2) by DEAE-dextran facilitation. Cells received TPA and A23187 2.5 h posttransfection; they were
harvested after 12 h of stimulation, and lysates from 3 x 107 cells were tested for CAT activity in a 5-h assay. This is experiment 1 in Table
1. Lanes marked - and + are negative and positive assay controls, respectively. The arrow indicates the primary reaction product.
a much larger percentage of CD4+ CD8+ (PNA+-type)
contaminants in the PNA- pool (Fig. 1A; see Materials and
Methods), it is possible that cortical-type cells even account
for some of the transfectability in the mature cell population.
This result contrasts dramatically with the behavior of
PNA+ and PNA- fractionated cells in typical assays of
immune function, in which PNA+ cells are almost com-
pletely devoid of activity and the enrichment of responsive-
ness in the PNA- fraction is conspicuous (6, 37). Thus, the
fractionation behavior of the transfectable thymocytes is
opposite to that of functionally competent cells.
The ratio of pRSV-Cat activity to pSV2-Cat activity in the
transfected thymocytes provided evidence that most of the
thymocytes expressing exogenous DNA were physiologi-
cally distinct from the T-lineage cell lines that have been
transfected before. Unlike the factor-dependent cell line
MTL.2.8.2 or the EIA.E1 thymoma (41; see below), these
cells showed a strong preference for the SV40 early pro-
moter over the RSV LTR (Fig. 1B). The ratio of pRSV-Cat
Normalized
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FIG. 2. Evidence that endogenous murine retrovirus LTRs are
stronger promoters than the SV40 early promoter in cortical-type
thymocytes. PNA+ thymocytes from 5-week-old B6 mice were
transfected with various promoter-CAT constructs as indicated.
Three hours posttransfection, cells received DMSO (-) or TPA plus
A23187 (+). Twelve hours later, they were harvested for CAT
assay. CAT activity is presented as normalized units per 107 cell
equivalents, where 1 U is the activity in the stimulated pSV2-Cat
sample, calculated after subtracting the background radioactivity of
the negative control. Arrows indicate the primary reaction product.
activity to pSV2-Cat activity (R/S ratio) was <0.05 for both
PNA+ thymocytes and the total thymocyte population
whose response they dominated (Table 1). These results did
not reflect differential uptake or retention of the two plas-
mids by thymocytes, as we shall show below (see Fig. 6).
Notably, the mature thymocytes showed a less marked
preference for pSV2-Cat in cases in which their transient
expression could be monitored at all. PNA- fractions typi-
cally contained too many cortical cells to give clear results.
However, cortical thymocytes could be removed completely
by cytolytic elimination with anti-CD8 plus complement.
The resulting population of mature CD4+ CD8- cells and
CD4- CD8- cells was then able to express pRSV-Cat
one-third as well as pSV2-Cat. The distinctive, much stron-
ger bias for pSV2-Cat over pRSV-Cat in the cortical thymo-
cyte population provides further evidence that the transfect-
TABLE 1. Preference of transfected thymocytes for the
SV40 early promoter'
CAT activity'
Expt Strain Cells
RSV SV40 R/SC
1 B6 Unfractionated <0.005 0.043 <0.12
PNA+ <0.006 0.080 <0.075
PNA- <0.005 0.015 <0.33
2 B6 PNA+ 0.051 1.1 0.05
PNA- 0.025 0.32 0.08
3 BALB/c PNA+ <0.008 0.32 <0.025
PNA- <0.005 0.022 <0.23
4 B6 PNA+ 0.032 2.2 0.015
PNA- ND 0.1
5 B6 CD8-d 0.016 0.049 0.33
G Thymocytes, either unfractionated, PNA panned, or antibody-plus-com-
plement eliminated, were prepared from the indicated strains of mice as
described in Materials and Methods. Each population was then transfected
with pRSV-Cat and pSV2-Cat. Two hours posttransfection, cells received
TPA plus A23187. Cells were harvested 12 h later, and lysates from equal cell
numbers were assayed for CAT.
' Expressed as percent acetylation per i07 viable cell equivalents in a 5-h
assay. ND, not done.
I R/S = (CAT activity with pRSV-Cat)/(CAT activity with pSV2-Cat).
d These cells were 58% CD4+, 41% CD4-CD8-, <1% CD8+ when trans-
fected.
_i An _.. ..._,_ _.
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TABLE 2. Evidence that cells with a strong preference for the SV40 regulatory region are small cortical thymocytesa
ElutnatedCAT activityb % of Calculated % of CAT
Elutriated~ ~ ~ ~ ~ ~ iit"% of activity in thymusdEractedn Cell recoveredfra ion RSV SV40 R/Se cellsc (iv) RSV SV40
(i) (ii) (iii) (v) (vi)
M/L PNA+ 0.40 1.24 0.32 5.3 60.3 27.6
M/L PNA- 0.15 0.33 0.45 3.3 14.4 4.6
S/I PNA+ 0.009 0.19 0.05 81.3 21.0 64.4
S/I PNA- 0.015 0.08 0.19 10.1 4.3 3.4
a Thymocytes were separated into two size fractions by centrifugal elutriation. In this experiment, 8.6% of the cells were recovered in the M/L fraction. Cells
were further fractionated by PNA panning before being transfected with pRSV-Cat and pSV2-Cat.
I Expressed as percent acetylation per 107 viable cell equivalents in a 5-h assay. All cells were stimulated with TPA plus A23187 for 12 h prior to assay.
c The recovery of viable cells from elutriation was 98% of input. The recovery from the PNA panning was 41% from the M/L fraction and 49% from S/I fraction.
Yield calculations in the last three columns are presented on the assumption that losses are random.
d Calculated for each fraction (n) as
100 x (CAT activity)n x (% of recovered cells),,
4
> [(CAT activity),m x (% of recovered cells)m]
m=t
where m is the number given to each of the four fractions.
I R/S = (CAT activity with pRSV-Cat)/(CAT activity with pSV2-Cat).
able cells enriched therein are not contaminants from
another thymocyte subset.
The expression of pSV2-Cat in cortical thymocytes was
surprising given the developmental end stage that most of
these cells represent. To rule out the possibility that this
expression was an artifact due to aberrant transcriptional
initiation from plasmid sequences, PNA+ cells were trans-
fected with an enhancerless derivative of this plasmid.
pUC18-Cat contains only the proximal 22 bp of the SV40
72-bp repeats and lacks a functional enhancer (25). When
transfected into PNA+ thymocytes, this deletion results in a
sixfold decrease in expression relative to expression from
the intact SV40 early promoter (Fig. 2; compare SV2 lanes
with pUC18 lanes; also data not shown). Therefore, utiliza-
tion of the SV40 early promoter in these cells is dependent
on a functional enhancer.
To explore further whether the transfectable cells in the
PNA+ population were typical cortical thymocytes, we
subjected them to additional fractionation steps. The rela-
tively low levels of CAT activity expressed per cell made it
necessary to transfect considerable numbers of thymocytes
to achieve results above the threshold of detection. Multi-
parameter fluorescence-activated cell sorting would be com-
pletely inadequate to supply these cell numbers. However, a
biologically significant difference among cortical thymocytes
is correlated with cell size. Although most cortical thymo-
cytes are small, postmitotic, and apparently terminal cells,
some are large blast cells with the ability to expand and
generate double-positive and single-positive populations
upon transfer into a normal thymus (26, 39). To take advan-
tage of this difference, we combined PNA panning with size
fractionation by centrifugal elutriation (10, 32, 36, 37). We
have previously shown that approximately 90% of thymo-
cytes belong to the small and intermediate (S/I) classes, and
almost all of them are in Go (5). On a per-cell basis, they
contain 10-fold less cytoplasmic RNA than do medium and
large (M/L) thymocytes. These M/L cells are mostly in the
Gl, S, and G2+M phases of the cycle and contain more than
two-thirds of the RNA found in the thymus even though they
represent only -10% of total thymocytes (32).
To test whether these large cycling cells were responsible
for the expression of transfected plasmid DNA, we PNA
fractionated thymocytes which had first been separated into
S/I and M/L fractions by centrifugal elutriation. The result-
ing four populations were transfected with either pRSV-Cat
or pSV2-Cat and then stimulated for 12 h with TPA and
A23187 before being assayed. The results (Table 2) show
that both large and small cells contribute to the transient
expression pattern but that the cells in the two size classes
behave differently. As predicted, the blast cells expressed
more CAT activity per cell than did the small cells (Table 2,
columns i and ii). However, the blast cells showed only a
slight bias in favor of SV40 expression over RSV, with R/S
values of 0.3 to 0.5 (Table 2, column iii). Thus, they could
not be responsible for the predominance of SV40 expression
in the total thymocyte or total PNA+ cell populations (cf.
Fig. 1B). The cells with the most marked preference for
SV40 over RSV were in fact found in the S/I PNA+ fraction
(R/S of 0.05). Although these small cells were less efficient
per cell than the blasts in transient expression, in the
aggregate they could account for almost two-thirds of the
SV40 early region utilization by thymocytes overall (Table 2,
column vi). Thus, cells with the size and surface properties
of small cortical thymocytes are competent to express exog-
enous DNA and account for the distinctive preference of
bulk thymocytes for the SV40 over the RSV promoter.
Murine retrovirus LTRs are extremely strong promoters in
thymocytes. Although both the RSV LTR and the SV40 early
promoter can be utilized by freshly isolated T cells, neither
virus normally infects mice, and thus these promoters are
not operating in an evolutionarily selected cellular context.
By comparison, LTRs from murine leukemia viruses would
be expected to function even better than these promoters in
transfected thymocytes and T cells. Figure 2 shows a repre-
sentative CAT assay of PNA+ thymocytes that had been
transfected with constructs containing promoters from two
murine thymic leukemia viruses. The plasmid pMCF-Cat
contains the intact LTR, which provides both a promoter
and an enhancer, from the lymphomagenic murine leukemia
virus MCF-13 (61). Recombinant MCF retroviruses of this
type cause primarily cortical thymomas in the AKR strain of
mice (11, 13, 43). pAkv-Cat contains the LTR from a
nonpathogenic, endogenous AKR retrovirus, Akv. When
introduced into PNA+ thymocytes, both of these plasmids
were expressed at high levels, yielding even more CAT
activity than did the intact SV40 early promoter (Fig. 2;
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compare SV2, MCF, and Akv lanes). This increase in
expression depends on both the enhancer and promoter
regions of the viral regulatory sequence, because hybrid
constructs containing the SV40 proximal promoter and ei-
ther the MCF-13 or the Akv enhancer region (pMS1 and
pAS1, respectively) were expressed no better than was
pSV2-Cat (Fig. 2). Examples of such promoter-dependent
enhancer activity have been reported previously (3).
In each case, expression of the viral promoter was signif-
icantly enhanced if the cells were induced with TPA plus
A23187 for 12 h after the transfection (compare + and -
lanes in Fig. 2). This finding suggests that rate-limiting
transcription factors for all of these viral regulatory se-
quences may be among the set that can be activated in T
cells in response to elevated Ca2+ concentrations and acti-
vation of protein kinase C. Furthermore, if the transfectable
cells in the PNA+ population are representative of cortical
thymocytes generally, it suggests that these cells are able to
display some inducible changes in transcription factor
expression even if these are not sufficient to activate tran-
scription of the IL-2 and IL-2 receptor a-chain loci (6, 51).
Immature thymocytes show little preference for RSV or
SV40. Small cortical thymocytes are the product of a com-
plex series of proliferative and differentiative processes that
act on thymocytes over a period of at least a week (55). Their
properties may not, therefore, be truly those of immature
cells but rather those of cells at a penultimate choice point.
Our results with enriched thymic blast cells, which include
the immediate precursors of small cortical cells, suggested
that the strongly biased R/S ratio might not be characteristic
of earlier precursors (Table 2). To examine this question
more directly, we tested the ability of immature, TcR-
negative CD4- CD8- (double-negative) thymocytes to ex-
press our panel of viral promoters. These cells are normally
a small minority of thymocytes which must be isolated via
prolonged incubation with antibodies and complement. To
avoid potential artifacts in preparing immature cells, we used
thymocytes from C.B-17 scid/scid mice. Mice homozygous
for the scid mutation (SCID) are defective in their ability to
rearrange functional TcR and immunoglobulin genes, and
the only viable cells in their thymuses are those that have not
progressed beyond the CD4- CD8- stage of development
(4). As shown in Fig. 3A, SCID thymocytes were at least as
transfectable as normal thymocytes overall when assayed
with the strong pMCF-Cat construct. Unlike most normal
thymocytes, however, SCID thymocytes were capable of
expressing the pRSV-Cat and pSV2-Cat constructs about
equally well, albeit both less efficiently than the MCF
construct (Fig. 3B and data not shown; R/S ratios of 1.3 and
0.8 in two experiments). Thus, the immature thymocytes
present in the SCID mouse, like the dividing blast cells in the
normal thymus, can be transfected for transient expression
but exhibit an R/S ratio that is clearly distinct from that of
the dominant transfectable population of normal cortical
thymocytes.
Transfected spleen T cells differ from thymocytes by their
requirement for prior activation and their slight preference for
the RSV LTR. Because thymocytes are intermediates in
T-cell development, it was of interest to determine whether
their mature progeny exhibited the same strong bias in favor
of the SV40 early promoter. Preliminary experiments used
B-cell-depleted spleen cells (65 to 85% Thyl+) or unfraction-
ated splenocytes as DNA recipients. Cells were transfected
with CAT constructs, cultured for 24 h, and then stimulated
overnight with TPA and A23187 before being assayed. In
contrast to freshly isolated thymocytes, no CAT activity
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FIG. 3. CAT expression in transfected SCID thymocytes. (A)
SCID thymocytes express transfected DNA similarly to normal
thymocytes. Unfractionated thymocytes from 4- to 6-week-old B6
and SCID mice were transfected with the indicated plasmids, and 4
h later they were stimulated with TPA plus A23187. Cells were
harvested 12 h later, and extracts from 1.6 x 106 to 2.8 x 106 cells,
as indicated, were assayed for CAT activity. (B) Expression of
different viral promoters in SCID thymocytes. Thymocytes from 3-
to 4-week-old SCID mice were transfected with the indicated
plasmids, and 4 h later they were stimulated with TPA plus A23187.
Cells were harvested after 12 h of stimulation, and extracts from the
indicated number of cells were assayed for CAT activity. A longer
exposure (not shown) demonstrated that SV2 was expressed slightly
better than RSV in this experiment, although in at least one other
experiment, RSV was expressed slightly better than SV2. Lanes
marked - and + are negative and positive assay controls.
could be detected in the lysates of these cells (Table 3,
experiments 1 and 2, and data not shown). Control experi-
ments ruled out the possibility that these cells were deficient
in DNA uptake. Gel blot analysis of total nuclear DNA
isolated 2 days posttransfection showed that cells contained,
on average, 5 to 10 copies of plasmid DNA (not shown),
which is 5- to 10-fold less than found in thymocytes. Freshly
isolated spleen cells, however, have a low cytoplasmic-to-
nuclear ratio, which might limit DNA uptake to a level below
that required for detectable expression of the CAT reporter
gene. To circumvent this problem and to increase the
proportion of T cells in the population, B-cell-depleted
splenocytes were first cultured for 3 days in the presence of
ConA. These mitogen-activated blasts (>95% Thyl+) were
then transfected with CAT plasmids and cultured for another
24 h before being treated with phorbol ester and ionophore.
Cells were harvested for assay after 18 h of stimulation. As
shown in Table 3 and Fig. 4, this protocol resulted in easily
detectable CAT expression by spleen T cells. Like thymo-
cytes, these cells expressed the MCF and Akv LTR con-
structs very well, about sixfold better than either of the other
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TABLE 3. Preference of transfected spleen ConA blasts
for the RSV LTR
CAT activity
Expt Spleen cellsa Treatmente
RSV SV40 R/Sd
1 B cell depleted None 0 0
2 B cell depleted None 0 0
B cell depleted 3d ConAe 0.40 0.043 9.3
3 B cell, CD4 depleted 3d ConA 20.0 9.2 2.2
B cell, CD8 depleted 3d ConA 3.7 2.2 1.7
4 Whole spleen 3d ConAf 0.83 0.85 1.0
a Spleen cells from B6 mice were depleted of B cells by panning on
anti-immunoglobulin-coated plates except in experiment 4. In experiment 3,
these cells were also depleted of either CD4+ or CD8+ cells by antibody-plus-
complement elimination.
b Purified cell populations were transfected with pRSV-Cat and pSV2-Cat
either immediately after isolation or after 3 days of culture with 4 ,ug of ConA
per ml (3d ConA). Twenty-four hours posttransfection, cells received TPA
plus A23187; they were harvested for assay 18 h later.
c Expressed as percent acetylation per 107 viable cell equivalents in a 5-h
assay.
d R/S = (CAT activity with pRSV-Cat)/(CAT activity with pSV2-Cat).
e These cells were 88% CD8+, 9% CD4+ at the time of transfection.
f These cells were 47% CD8+, 30% CD4+ at the time of transfection.
constructs. However, in contrast to cortical thymocytes,
these cells used the RSV LTR at least as efficiently as the
SV40 early region, with R/S ratios ranging from 1.0 to a high
value of 9.3. While these cells were robust enough to allow
both a longer recovery time after transfection and a longer
period of stimulation than did thymocytes, the altered con-
ditions were not the cause of their different pattern of
promoter utilization. When day 3 ConA blasts were trans-
fected and stimulated exactly like thymocytes, they main-
tained R/S values near 1, even though the absolute levels of
expression were somewhat lower (data not shown). Stimu-
lation with ConA plus IL-2 led to the outgrowth of CD8+ T
cells primarily, and in a direct comparison, the modest
preference for the RSV LTR was somewhat more pro-
nounced in CD8+ cells than in CD4+ cells (Table 3, exper-
iment 3). Nevertheless, strong expression of pRSV-Cat at
least equal to that of pSV2-Cat remained a general feature of
both subsets of ConA blasts.
All of the data presented in Table 3 are from ConA blasts
further stimulated with TPA and A23187. As shown in Fig. 4
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FIG. 4. Murine retroviral LTRs function efficiently in spleen
ConA blasts. Spleen cells from 7-week-old B6 mice were cultured
for 3 days in the presence of ConA. Activated cells were then
transfected with the indicated plasmids. Twenty-four hours after
transfection, cells were either stimulated with TPA plus A23187 (+)
or left unstimulated (-). The cells were harvested 18 h later, and -6
x 106 cells were assayed for each sample. The absolute percent
acetylation values for the samples were as follows: RSV unstimu-
lated, <0.01; RSV stimulated, 0.5; SV2 unstimulated, <0.01; SV2
stimulated, 0.47; Akv unstimulated, 0.13; Akv stimulated, 3.0; MCF
unstimulated, 0.05; MCF stimulated, 2.9.
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FIG. 5. Effect of ConA preculture on spleen T-cell CAT expres-
sion. B-cell-depleted spleen cells were cultured in the presence of
ConA for 2, 3, or 4 days. On the day indicated, cells were harvested
and transfected with pRSV-Cat. Transfected cells were cultured for
an additional 24 h in the presence of IL-2 before receiving DMSO
(-) or TPA and A23187 (+). After 18 h of stimulation, equal
numbers of cell equivalents were assayed for CAT activity. Thus,
day 2 ConA blasts were actually assayed 4 days after removal from
the mouse. Relative CAT activity was calculated by normalizing the
actual percent acetylation of each sample with respect to the value
for the day 2 (-) sample, which was arbitrarily set to 1.0. Data are
presented as means and ranges of two independent experiments.
and 5, without this treatment blasts produced detectable, but
substantially lower, levels ofCAT activity. Thus, even in the
physiological context of the proliferating ConA blast, all four
viral promoters behaved as elements acutely dependent on
A23187-TPA induction. We have examined two other vari-
ables which affect the detection of reporter gene expression
in spleen T cells. The duration of preculture in ConA prior to
transfection strongly affected the level of CAT activity.
Figure 5 shows that transfectability of the cells, as measured
later by inducible CAT expression, increased sharply be-
tween 2 and 3 days of preculture in ConA and remained high
for at least another 24 h. Inclusion of IL-2 in the culture
medium after transfection resulted in the recovery of 5 to 10
times more CAT activity in day 3 and day 4 ConA blasts but
had little effect on day 2 ConA blasts (data not shown). Thus,
the 3-day preculture with ConA seemed to be required to
confer the competence to express exogenous DNA on the
splenic T cells, in a process distinct from the further modu-
lation of expression level via A23187-TPA induction or via
IL-2-dependent growth.
Growth factor-dependent T-cell lines exhibit a strong pref-
erence for the RSV LTR. Established clonal cell lines,
continuously growing in response to IL-2, were examined to
compare their behavior with that of freshly isolated T cells.
Transfection of several nontransformed, IL-2-dependent cell
lines with pRSV-Cat and pSV2-Cat revealed a marked
preference for the RSV LTR in these cells (Fig. 6 and 7;
Table 4). R/S values ranged from 11 to 50, irrespective of
whether or not the cells were stimulated with phorbol ester
and ionophore (Fig. 6 and data not shown). The cell lines
tested included a pair of cytotoxic T-lymphocyte lines,
CTLL-2 and MTL2.8.2, and an IL-4-inducible Th2-like line,
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FIG. 7. Comparison of promoter preference in the CTLL-2 and
EL4.E1 cell lines. The IL-2-dependent line CTLL-2 and the IL-2-
independent thymoma EL4.E1 were transfected with pBR322,
pRSV-Cat, or pSV2-Cat as indicated. Twenty-four hours posttrans-
fection, one half of the cells were stimulated with TPA plus A23187
(+) and the remaining half received DMSO as a solvent control (-).
Cells were harvested for assay 18 h later.
FIG. 6. Evidence that the disparate promoter preferences of
transfected PNA+ thymocytes and CTLL-2 cells are not due to
differences in plasmid copy number. BALB/c PNA+ thymocytes
and CTLL-2 cells were transfected in parallel with pRSV-Cat and
pSV2-Cat. Cells were stimulated as described in Materials and
Methods and harvested after either 16 h (thymocytes) or 42 h
(CTLL-2 cells) of culture. One half of the cells (1.1 x 107 thymo-
cytes and 1.7 x 106 CTLL-2 cells) were assayed for CAT activity.
Low-molecular-weight plasmid DNA was extracted from the other
half of the cells by the method of Hirt (28a). DNA from 3 x 105 cell
equivalents was electrophoresed, transferred to a nylon filter, and
hybridized with a probe for the pBR322-derived sequences as
described in Materials and Methods. (A and B) CAT assays from
extracts of transfected PNA+ thymocytes (A) and CTLL-2 cells (B).
The thymocyte and CTLL-2 extracts were assayed for CAT activity
under the same conditions but analyzed on separate chromatogra-
phy plates. - and + indicate the negative and positive assay
controls, respectively. The upper bracket indicates the major reac-
tion products, and the lower bracket indicates the unreacted
[14C]chloramphenicol. (C and D) DNA samples extracted from cells
assayed in panels A and B: (C) PNA+ thymocytes; (D) CTLL-2
cells. The samples shown in panels C and D were analyzed on the
same gel and hybridized simultaneously, but panel C is from an
autoradiographic exposure time of 48 h, whereas panel D is from an
autoradiographic exposure of 2 h. Lanes: R, DNA from cells
transfected with pRSV-Cat; S, DNA from cells transfected with
pSV2-Cat.
HT-2, suggesting that the preference for RSV over SV40 is
not restricted to a particular T-cell sublineage.
Similar results were also obtained with the IL-3-dependent
premast cell line 32Dcl5. Although this line is presumably of
a myeloid lineage, it can be induced to express IL-4 like a
Th2 cell (7, 42). Lines similar to this have been shown to
express low-affinity IL-2 receptors and may gradually be
adapted to growth in IL-2 (33, 35). Like the IL-2-dependent
lines, 32Dc15 cells are absolutely dependent on the contin-
ued presence of an appropriate growth factor, and they die
rather than arrest their growth when IL-3 is depleted. When
these cells were transfected with pRSV-Cat and pSV2-Cat,
they also exhibited a 20-fold preference for the RSV LTR
(Table 4).
The sharply contrasting R/S ratios of cortical thymocytes
and factor-dependent cells were not due to differential DNA
uptake. This is illustrated by the experiment shown in Fig. 6.
PNA+ thymocytes and CTLL-2 cells differ greatly from one
another in their overall efficiencies in DNA uptake (compare
Fig. 6C [48-h exposure] with Fig. 6D [2-h exposure]), but in
each cell type the levels of pRSV-Cat DNA that were taken
up and retained were indistinguishable from the levels of
pSV2-Cat DNA. An overwhelming preference for pSV2-Cat
expression was shown by the thymocytes (Fig. 6A), and an
overwhelming preference for pRSV-Cat expression was
shown by the CTLL-2 cells (Fig. 6B), at the same times of
incubation when they demonstrably contained equal
amounts of pSV2-Cat and pRSV-Cat DNA. The character-
istic R/S ratios of the different cell types must therefore
reflect differential promoter utilization.
Similar results demonstrating a preference for the RSV
LTR over the SV40 early promoter have been reported by
Gorman and coworkers for a variety of primate and rodent
fibroblast lines, employing both transient and stable expres-
sion systems (23, 24). However, as discussed below, for
murine T-cell lines, such a strong preference for the RSV
LTR may be restricted to a discrete activation state associ-
ated with factor-dependent growth.
IL-2-independent T-cell lines show little promoter prefer-
ence. Malignant leukemia and lymphoma cell lines of T-lin-
eage origin are frequently used in transfection studies to
TABLE 4. Preference of growth factor-dependent cell lines
for the RSV LTR'
CAT activityb
Cell Cell Ext1xp2line type StExpt2 R/S
RSV SV40 RSV SV40 (expt 1, expt 2)
CTLL-2 CTLd 11.0 1.0 2.0 0.18 11, 11
MTL2.8.2 CTL 1.1 0.034 0.32 <0.01 32, >32
HT-2 Th2 0.14 0.0025 3.3 0.1 56, 33
32Dc15 Premast 20 0.81 9.5 0.43 25, 22
a Exponentially growing cells were transfected with pRSV-Cat or pSV2-
Cat, and 24 h later cells received TPA plus A23187. Cells were assayed for
CAT 18 h later.
b Expressed as percent acetylation per 106 viable cell equivalents in a 5-h
assay.
cR/S = (CAT activity with pRSV-CAT)/(CAT activity with pSV2-Cat).
d CTL, cytotoxic T lymphocytes.
CTLL-2 EL4.E1
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TABLE 5. Evidence that growth factor-independent cell lines show little promoter preference when transfected with
pRSV-Cat and pSV2-Cat
CAT activityb
Cell line Type Stimulation' Expt 1 Expt 2
,/SC
RSV SV40 RSV SV40 (expt 1, expt 2)
EL4.E1 Thymoma 0.87 0.21 4.0 1.6 4.1, 2.4
+ 2.4 0.80 42.0 30.0 3.0, 1.4
Jurkat T-cell leukemia - 5.8 2.0 0.73 0.15 2.9, 4.9
+ 9.3 12.5 2.0 2.3 0.7, 0.9
BW5147 Thymoma 0.36 0.24 0.70 0.30 1.5, 2.3
+ 2.6 6.3 4.2 4.0 0.4, 1.0
AO1T-2.11 T hybridoma 0.55 0.22 0.55 0.22 2.5, 2.5
+ 1.0 0.40 1.1 0.65 2.5, 1.7
728 Thymoma 0.08 0.08 0.025 0.045 1.0, 0.6
+ 0.26 0.34 0.13 0.09 0.8, 1.4
629 Thymoma 0.30 0.46 0.03 0.09 0.6, 0.3
+ 1.2 0.9 0.15 0.05 1.3, 3.0
R1.1 Immature thymoma - 0.01 0.002 0.006 0.001 5.0, 6.0
+ 0.008 0.002 0.02 0.009 4.0, 2.2
705 Immature thymoma - 0.006 0.009 0.002 0.009 0.7, 0.2
+ 0.034 0.014 0.008 0.007 2.4, 1.1
-, unstimulated; +, 18-h stimulation with TPA plus A23187.
b Expressed as percent acetylation per 106 viable cell equivalents in a 5-h assay.
CR/S = (CAT activity with pRSV-Cat)/(CAT activity with pSV2-Cat).
model T-cell behavior, so we compared examples of these
cell types with the primary and factor-dependent T cells
described above. In contrast to the results obtained with
growth factor-dependent cell lines, results from a panel of
T-cell hybridomas and thymomas revealed only a slight
preference, if any, for RSV over SV40 (Fig. 7 and Table 5).
These modest R/S values (-2 to 5) were usually greater in
unstimulated cells than in cells which had been stimulated
overnight with phorbol ester and calcium ionophore, and in
some cases stimulation resulted in R/S ratios that were
slightly less than 1 (see, e.g., Jurkat cells in Table 5). The
tumor cell lines in this panel were all rapidly and continu-
ously growing, with cycle times quite comparable to those of
the growth factor-dependent cells. Thus, a strong preference
for RSV over SV40 is not a necessary consequence of rapid
growth. On the other hand, all of the tumor cells also failed
to match the R/S ratio of cortical thymocytes, even though
some of them expressed certain aspects of cortical thymo-
cyte phenotype. For example, the R1.1 thymoma appears to
represent an immortalized cortical thymocyte by virtue of its
high-level expression of the cortical thymocyte markers TL
and terminal deoxynucleotidyltransferase (49b). The AKR
thymoma lines 705, 629, and 728 also represent transitional
thymocyte stages (44). All three lines lack surface TcR
expression but differ in their expression of ax- and 13-chain
mRNAs. Line 705 represents an immature thymocyte type,
CD- CD8- and lacking TcR a-chain mRNA. Line 629 is also
CD4- CD8- but expresses both ax- and ,3-chain mRNAs, and
line 728 not only expresses TcR ax- and 1-chain mRNAs but
is also double positive. Nevertheless, all three AKR lines
have R/S ratios of about 1, and line R1.1 frankly prefers the
RSV promoter (Table 5). Thus, the growth state of the
transformed cells appears to preclude their use of the same
promoter hierarchy as their presumed normal counterparts.
DISCUSSION
T-cell development proceeds through a complex series of
intermediate stages which can be characterized, in part, by
differential expression of stage-specific gene products. Thy-
mocytes also differ in the extent to which they are capable of
being induced to express genes which they do not constitu-
tively transcribe. We have used a simple protocol, measur-
ing the relative expression of viral promoter constructs, to
demonstrate two points. First, both thymocytes and spleen
T cells are easily transfected and can express levels of the
CAT reporter gene which are readily detectable in a 5-h
assay. Second, even within the T-cell lineage, commonly
used positive control constructs are subject to sharp differ-
ential regulation, with their relative strengths shifting and
even reversible as a function of developmental or growth
state. The relative expression of the RSV and SV40 regula-
tory regions thus seems not to be dominated so much by the
presence or absence of lymphoid-specific transcription fac-
tors per se as by sweepingly changeable patterns of general
transcription factor expression that distinguish cortical thy-
mocytes from their precursors, from their splenic progeny,
and from cell lines derived from them.
Our results using DEAE-dextran to transfect murine
splenic T cells are in good agreement with those of Cann et
al. (9), who described conditions for transfecting human
peripheral blood lymphocytes by electroporation. T cells
from both sources are mature and predominantly in a resting
state. As in our experiments, the human lymphocytes report-
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edly required 3 days of prestimulation with the mitogen
phytohemagglutinin plus IL-2 before transfection in order to
express detectable CAT activity, even though they could
take up DNA without prestimulation. According to the
published data, these mitogen-stimulated human T cells had
an R/S ratio of -0.5, in reasonable agreement with the
similar ratios of expression that we observed in murine
ConA blasts. In our hands, however, the effect of prestim-
ulation to confer competence could be separated from a
further acute effect of TPA-A23187 induction after transfec-
tion to enhance expression. ConA blasts expressed CAT
from all four viral promoters much better after such induc-
tion, even though the cells had already become activated and
involved in the cell cycle. This finding suggests that a
function directly controlled by Ca2+ flux and protein kinase
C activation, and not merely an outcome of mitogenesis in
general, influences exogenous DNA expression. While our
data do not formally rule out a posttranscriptional effect,
e.g., at the level of translation, there are well-established
precedents for genes whose transcriptional activity in T cells
shows this pattern of regulation, for example, the IL-2 and
gamma interferon lymphokine genes (28). Thus, rate-limiting
regulatory factors for all of these viral promoters may be
controlled by Ca2+-protein kinase C activation in T cells.
Our unexpected finding was how accessible murine thy-
mocytes were for transfection and short-term expression of
the exogenous DNA. Populations of thymocytes required no
prestimulation in order to become competent to express
these DNAs, even though TPA-A23187 treatment after
transfection enhanced reporter gene expression as described
above. Our data indicate that at least two developmentally
distinct populations of thymocytes participate in this re-
sponse. This conclusion is based on the fractionation behav-
ior of the transfectable cells, coupled with the relative
recoveries of pRSV-Cat expression versus pSV2-Cat expres-
sion in different thymocyte subsets. If this conclusion proves
to be sound, then the two types of thymocytes that can be
transfected are, respectively, immature (TcR-) thymic blast
cells and small cortical thymocytes.
The involvement of immature thymic blasts is not unex-
pected, as these are cells with high RNA contents, high
protein synthesis rates, short cell cycle times in vivo, and
excellent viabilities in vitro (8, 32, 40, 46, 51). This actively
dividing minority of cells includes immediate precursors of
most cortical thymocytes, but our data do not demarcate the
precise stages of development that limit the transfectable
state. SCID thymocytes, most of which are arrested at a
CD4- CD8- IL-2 receptor' TcR- stopping point before the
final proliferative stage, include transfectable cells with an
R/S ratio similar to that of normal thymic blast cells. While
all are immature, it remains to be determined whether the
cells in the SCID thymus that are transfectable are repre-
sentative of the majority or merely a subset.
The immature blast cells do not represent all of the
transfectable normal thymocytes, because while the blasts
express RSV and SV40 promoters approximately equally,
the total population shows at least 20-fold better activity
with the SV40 promoter. Our fractionation data imply that
the additional subset involved is that of the small cortical
thymocytes. This is a surprising conclusion given the noto-
rious fragility of these cells and their well-documented
refractoriness in conventional responses to stimulation. The
ability of small PNA+ cells to be transfected is not due to
their being in an actively cycling state, because on the basis
of DNA content such cells are clearly in Go/Gl (5, 36, 49c),
as are resting splenic T cells. On the other hand, several lines
of evidence have long suggested that the resting state of
cortical cells is at least an unusual one. They retain high
concentrations of deoxynucleoside triphosphates, unlike
most resting cells (14, 31), and high-level expression of
proliferation-associated c-onc gene expression (54, 57, 58).
Their persistent high-level expression of the DNA polymer-
ase terminal deoxynucleotidyltransferase (38, 48) is also
unexpected for resting cells. Thus, the unconventional phys-
iological state of these cells may act to facilitate their
processing of exogenous DNA for expression, in a way that
other cells do efficiently only when in cycle.
While the MCF and Akv LTRs exhibit high promoter
activity in ConA blasts, cortical thymocytes, and immature
SCID thymocytes alike, the RSV LTR and SV40 early
region respond very differently to different cellular contexts.
Whereas ConA blasts and immature thymocytes utilize both
comparably well (R/S from 0.3 to 3), RSV and SV40 expres-
sion patterns are divergently skewed in cortical thymocytes
(R/S < 0.05) and IL-2-dependent, nonmalignant cell lines
(R/S > 10). These reproducible differences, which are sus-
tained with or without TPA-A23187 treatment, imply that the
batteries of transcription factors available in cortical thymo-
cytes and factor-dependent T cells are at least quantitatively
different from those in T-lineage cells in other states. It is
possible that the R/S phenotype of the factor-dependent lines
is one which primary T cells also approach transiently, at
times when they enter a stage of IL-2-dependent prolifera-
tion. For example, there was a trend toward higher R/S
ratios in preparations of ConA blasts in which the more
IL-2-responsive CD8+ cells (27) had most outgrown the
CD4+ cells. However, our results clearly show that high R/S
ratios are not a consequence of proliferation per se. Dividing
thymic blast cells and a wide range of tumor cell lines were
largely indifferent to the two promoters. T cells proliferating
in a factor-dependent manner therefore appear to possess a
distinctive signature of regulatory proteins, leading to dis-
tinctive promoter preferences.
Cortical thymocytes appear at the opposite pole of regu-
latory physiology, with a virtual inability to utilize the RSV
LTR in spite of robust expression of the SV40 early region.
Definition of the basis of the RSV expression defect must
await fuller characterization of the transcription factors that
normally act on this LTR. SV40 regulatory factors, on the
other hand, are well defined, and it has recently become
possible to analyze thymocytes directly for their expression.
While such studies are in a very early stage, the initial results
appear quite compatible with those of our functional studies.
One general transcription factor that is required for efficient
expression of the SV40 early promoter is Spl (18, 21, 30). It
is interesting that thymocytes of 4- to 5-week-old mice
reportedly express higher levels of Spl mRNA than do any
other of a series of mouse tissues examined (52). The poor
expression of the enhancerless SV40 derivative pUC18-Cat,
which retains all six Spl sites of the normal SV40 promoter,
demonstrates that Spl protein-DNA interactions are not
sufficient for high-level transcription; however, high levels of
Spl are certainly consistent with the relatively strong utili-
zation of the intact SV40 promoter by the cortical thymo-
cytes. At least two additional binding sites in the SV40
enhancer are particularly likely to be engaged by cortical
thymocyte proteins, namely, the octamer motifs associated
with the twin SphI sites and the AP-1 sites immediately
downstream from them. Direct analysis of the binding pro-
teins in cortical thymocyte nuclear extracts shows abundant
constitutive octamer-binding activity (lla, 45). Further-
more, these cells can readily be activated to express a strong
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binding activity for AP-1-like sites, as well as another
inducible factor, CD28RC, which may bind to a sequence
similar to the target of AP-3 (lla). Many more factors remain
to be measured, but it seems likely that the bias of cortical
thymocytes toward expression of the SV40 early region
promoter will soon be substantiated in molecular terms.
In contrast to the SV40 and RSV regulatory regions, the
MCF and Akv LTRs are powerful promoters in both thymo-
cytes and ConA-treated spleen cells. One possible explana-
tion for the significantly greater activity of the MCF and Akv
LTRs would be the ability of certain enhancers and promot-
ers to function in a species-specific manner (2, 34). The
recent observation that the activity of the TFIID transcrip-
tion factor that binds to promoter sequences can be species
dependent in vivo (16, 22) may partly account for this
species specificity. Hence, the fact that the MCF and Akv
promoters are derived from murine retroviruses may con-
tribute to their increased expression relative to the RSV and
SV40 promoters, which are of avian and simian origin,
respectively. However, much remains to be learned about
the specific participants in protein-DNA and protein-protein
interactions on these LTRs. It has been shown that the MCF
and Akv enhancers contain discrete protein-binding sites
that have been implicated in the TPA responsiveness of the
LTR of the Moloney murine leukemia virus, which is related
to the MCF and Akv viruses (56). Although these protein-
binding sites may be important for the increase in transcrip-
tional activity detected for the MCF and Akv LTRs, it is
clear that they are not sufficient for this response, since these
viral enhancers are unable to activate the SV40 promoter in
the MS1 and AS1 constructs. Elucidation of such regulatory
interactions will be needed to explain the broad range of
T-cell types in which these LTRs are active. In contrast to
our earlier observation that the MCF LTR is transcription-
ally more active than the Akv LTR in T-cell lines (62), both
LTRs were equally active in PNA+ thymocytes. It is thought
that the MCF but not the Akv virus infects and transforms a
cycling subset of thymic cortical cells, i.e., the cortical blast
cell (12, 43). Based on the mechanism of insertional muta-
genesis by the MCF LTR in thymic tumors (15, 17), it has
been hypothesized that the MCF LTR would be more active
than the Akv LTR in such a population of cortical cells. One
reason we may not have detected any difference in transcrip-
tional activity between these two LTRs is that this blast cell
population represents only a small percentage of the PNA+
cells, and differences in CAT activity in this subset would be
obscured by the unexpectedly high expression of both LTRs
in the majority class of cortical cells. A definitive test of the
hypothesis thus awaits isolation of the critical cortical blast
cell subset and a direct comparison of the MCF and Akv
LTRs in that cellular context.
The CAT constructs used in this study were not intended
to be developmentally stage specific. While lineage-specific
elements have been implicated in their regulation, they were
used here as examples of positive control constructs against
which regulatory sequences implicated in lymphocyte re-
sponses could be compared. The results of these experi-
ments nevertheless show that within the T-cell lineage,
changes in the utilization of general transcription factors can
be extensive enough to allow common viral promoters to
serve as probes of developmental state and mitogenic mech-
anism.
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